Figure 5 | Scientific Reports

Figure 5

From: Development of an advanced flow cytometry based high-resolution immunophenotyping method to benchmark early immune response in dairy cows

Figure 5

Supervised Clustering of the results of Bovela treatment (group C), three components with a maximum of five features each. (A) sPLS-DA using all parameters (AUROC: “pre” vs others: 0.997, “post” vs others: 0.950, “late” vs others: 1.000); (B) sPLS-DA using blood parameters (AUROC: “pre” vs others: 0.896, “post” vs others: 0.847, “late” vs others: 0.987); (C) sPLS-DA using milk parameters (AUROC: “pre” vs others: 0.931, “post” vs others: 0.906, “late” vs others: 0.973); (D) sPLS-DA using the parameters analyzed by external laboratory (AUROC: “pre” vs others 0.979, “post” vs others: 0.959, “late” vs others: 1.000).

Back to article page